Publication:
Benchmarking ultra-low attachment and photopatterned GelMA 3D culture platforms for modeling cancer stemness in high-grade serous ovarian cancer

Placeholder

School / College / Institute

Organizational Unit
SCHOOL OF MEDICINE
Upper Org Unit
Organizational Unit
GRADUATE SCHOOL OF HEALTH SCIENCES
Upper Org Unit
Organizational Unit
Organizational Unit

Program

KU Authors

Co-Authors

Editor & Affiliation

Compiler & Affiliation

Translator

Other Contributor

Date

Language

eng

Embargo Status

N/A

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

High‐grade serous ovarian cancer (HGSOC) exhibits pronounced intratumoral heterogeneity and chemoresistance, demanding experimental platforms that more accurately recapitulate stemness‐driven relapse. Despite increasing use of three‐dimensional (3D) systems in cancer research, their comparative translational performance in ovarian cancer remains unclear. Here, we systematically benchmark two scalable 3D platforms, scaffold‐free ultra‐low attachment (ULA) spheroids and extracellular matrix mimetic photopatterned gelatin methacryloyl (GelMA) hydrogels, using HGSOC cell lines and patient‐derived primary samples. Under matched conditions, both systems enhanced cancer stem cell (CSC) associated phenotypes relative to 2D culture, including induction of stemness markers, CSC surface populations, epithelial to mesenchymal transition signatures, and drug resistance. ULA enabled long‐term spheroid maturation and robust expansion of intrinsically stem‐like populations, whereas GelMA photopatterning provided spatially defined microenvironmental control that promoted rapid and uniform spheroid formation and efficiently induced stem‐like traits in low‐stemness models. Notably, baseline SOX2 expression partially correlated with chemoresistance, supporting the biological relevance of CSC enriched platforms. Collectively, this platform level comparison establishes complementary, biotechnology driven strategies for reproducible modeling of HGSOC stemness and therapy resistance, with implications for translational drug evaluation and precision oncology.

Source

Publisher

Wiley

Subject

Health sciences, Medicine, Oncology, Physical sciences, Engineering, Biomedical engineering, Life sciences, Biochemistry, Genetics and molecular biology, Molecular biology

Citation

Has Part

Source

Biotechnology Journal

Book Series Title

Edition

DOI

10.1002/biot.70287

item.page.datauri

Link

Rights

Copyrights Note

Endorsement

Review

Supplemented By

Referenced By

Related Goal

0

Views

0

Downloads

View PlumX Details